))
Episode 23 - 2Q 2020 Results Bring Estimate Increases, But Can The Fed Inoculate The Economy?
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on February 26, 2024 14:59 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 280069225 series 2839981
Contenu fourni par Laidlaw Wealth Management. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Laidlaw Wealth Management ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
In this episode Richard Calhoun, CEO of Laidlaw Wealth Management, discusses takeaways from the 2Q 2020 earnings season, the ongoing complications from COVID and other developments with Laidlaw & Company Chief Market strategist, David Garrity.
The topics discussed in this episode are: With 2Q 2020 results prompting analysts to raise estimates, are stocks still attractive?, Are management share sales a red flag for stocks? Can The Fed fully offset COVID’s economic impact?, How might investors capitalize on the weakening U.S. Dollar?, and How should investors best operationalize “Quality” in portfolio construction?
66 episodes
Partager
